2'-deoxy-2'-methylenecytidine has been researched along with deoxyuridine in 1 studies
Studies (2'-deoxy-2'-methylenecytidine) | Trials (2'-deoxy-2'-methylenecytidine) | Recent Studies (post-2010) (2'-deoxy-2'-methylenecytidine) | Studies (deoxyuridine) | Trials (deoxyuridine) | Recent Studies (post-2010) (deoxyuridine) |
---|---|---|---|---|---|
30 | 2 | 0 | 2,256 | 22 | 446 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuoka, M; Kudoh, S; Masuda, N; Matsui, K; Myobudani, H; Nakagawa, K; Negoro, S; Nemoto, S; Nihira, S; Nogami, T; Ogawa, K; Okuda, T; Takeda, K; Takifuji, N; Yamada, M; Yamamoto, N | 1 |
1 trial(s) available for 2'-deoxy-2'-methylenecytidine and deoxyuridine
Article | Year |
---|---|
Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule.
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Carcinoma, Squamous Cell; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Deoxycytidine; Deoxyuridine; Dose-Response Relationship, Drug; Female; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Time Factors | 2000 |